Alleviant ALLAY-HFrEF Study

a study on Heart Failure

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Los Angeles, California and other locations
Dates
study started
study ends around
Principal Investigator
by Richard Cheng, MD

Description

Summary

Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.

Official Title

Safety and Efficacy of the Alleviant No-Implant Interatrial Shunt in Patients With Heart Failure and Reduced Ejection Fraction

Keywords

Heart Failure, Alleviant ALV1 System

Eligibility

You can join if…

Open to people ages 18 years and up

  • LVEF ≤ 40%
  • NYHA class II, III or ambulatory IV HF
  • Receiving optimal, maximally tolerated, stable GDMT

You CAN'T join if...

Locations

  • University California Los Angeles Medical Center accepting new patients
    Los Angeles California 90095 United States
  • Keck Medical Center of USC accepting new patients
    Los Angeles California 90033 United States

Lead Scientist at UCLA

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Alleviant Medical, Inc.
Links
Sign up for this study
ID
NCT06812533
Study Type
Interventional
Participants
Expecting 350 study participants
Last Updated
Contact us about this trial